الفهرس Only 14 pages are availabe for public view
 |  | from | 157 |  |  |
| | | from | 157 | | |
Abstract
Recurrent pleural effusion in patients with advanced cancer IS a
common problem that causes significant morbidity and can negatively
affect patient’s quality oflife for their remaining months.
The necessity for repeated aspiration the relieve dyspnea both
physically and psychologically traumatic to the patient and burden on the physician. Pleurodesis is the optimal therapy for malignant pleural
effusions, but the optimal method of pleurodesis and the optimal agent used
remain debatable. The optimal agent. for pleurodesis should be highly
effective, free of significant adverse effects, inexpensive and readily
available for the clinician.
Forty patients with malignant pleural effusion (MPE) were included
in our study. They were divided into two groups. Group (A):
Included twenty patients who were subjected to iodopovidone
pleurodesis. They included 7 males (35%) and 13 females (65%) with age
ranging from 19 years to 70 years with a mean of age 52.1 ± 14.1 years.
Group (B): Included twenty patients who were subjected to bleomycin
pleurodesis. They included 9 males (45%) and 11 females (55%) with age
ranging from 21 years to 67 years with a mean of age 51.7 ± 13.9 years.